Drug & intervention

amlexanox

RxCUI 46307

Clinical trials2

Recruiting0

Related conditions4

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Background context

Amlexanox

Amlexanox (trade name Aphthasol) is an anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. This drug has been discontinued in the U.S.

Read on Wikipedia ↗ Wikidata Q695611 ↗

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

2 shown

Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsNCT01975935 · 2014-01-01

COMPLETED

Amlexanox for Type 2 Diabetes and ObesityNCT01842282 · 2013-07-19

TERMINATED

Conditions being studied

Diabetes Mellitus Type 22 Obesity2 Non Alcoholic Fatty Liver Disease1 Non-alcoholic Fatty Liver Disease1

Research locations

Ann ArborMichigan, United States2

Leading sponsors

University of Michigan2

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.